Johnson & Johnson (JNJ)VA awarded $385K
VA awarded Johnson & Johnson a contract with $385K committed so far.
- $385K
- committed so far
- Signed
- Oct 5, 2026
- Updated
- Oct 5, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 10, 2026Federal contract · $198K obligatedDepartment of Defense awarded Johnson & Johnson: $198K obligated to date
- Jul 30, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
- Jul 30, 2026CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Aug 5, 2026Insider · 1 personInsiders: 2 sales (~$12.5M)
- Aug 6, 2026Insider · 1 personInsiders: 2 sales (~$4.1M)
- Aug 12, 2026FDARecall: Automated Impella Controller (AIC) with the below product descriptions and corresponding Product Codes. 1. Impella Controller, Packaged, CA; Product Code: 0042…
- Aug 12, 2026FDARecall: Impella Optical Controller with the below product descriptions and corresponding Product Codes. 1. Impella Optical Controller, Packaged, AU; Product Code: 0042…
- Aug 12, 2026FDARecall: Impella Optical Controller, Automated Impella Controller, Impella Connect Package with the below product descriptions and corresponding Product Codes. 1. Optic…
- Aug 13, 2026Insider · 1 personInsiders: 2 sales (~$32.2M)
- Aug 17, 2026Insider · Named in an 8-K 13 days earlierOfficer sold ~$3.95M of JNJ shares in the open market
- Aug 20, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Aug 24, 2026FDAFDA drug approval: Imaavy
- Aug 27, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Aug 28, 2026FDAFDA drug approval: Stelara
- Sep 2, 2026Federal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
- Sep 2, 2026Insider · 1 personInsiders: 2 sales (~$9.2M)
- Sep 4, 2026FDAFDA device clearance: ATTUNE Revision Knee System
- Sep 8, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Sep 17, 2026FDAFDA device clearance: HARMONIC 1100 Shears (HAR1120); HARMONIC 1100 Shears (HAR1136)
- Oct 5, 2026 · this disclosureFederal contract · $385K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $385K obligated to date
How to read USAspending.gov award record
The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.
Full guide: Contract ceiling vs obligated amount: the difference
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
How this filing works
Other disclosures at Johnson & Johnson
- House Clerk periodic transaction reportOct 5, 2026
- USAspending.gov award recordSep 22, 2026
- USAspending.gov award recordSep 21, 2026
- House Clerk periodic transaction reportSep 12, 2026
- Senate eFD periodic transaction reportSep 11, 2026
- SEC Form 4Sep 4, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
